Loading data for OSRH — first visit, this takes a few seconds.
OSR Health, Inc. (OSRH)
OTC Markets OTCPK: OSRH
· 即時價格 · USD
0.23
-0.01 (-4.17%)
收盤價： Sep 11, 2026, 7:59 PM
股價、關鍵數字和最新消息，都在這一頁。
OSR Health, Inc.（OSRH）股價、分析與資料
無可用資料
| 買價 | 0.2 |
| 市值 | 7.06M |
| 營收 (ttm) | 1.81M |
| 淨利（ttm） | -10.7M |
| 0.50 | |
| -0.3 | |
| n/a | |
| n/a | |
| P/B (ttm) | 0.07 |
| P/S (ttm) | 3.90 |
| 財報日期 | n/a |
| 賣價 | 0.23 |
| 成交量 | 318,676 |
| 20 日平均成交量 | 10,025,685 |
| 開盤價 | 0.24 |
| 前收盤價 | 0.24 |
| 當日區間 | 0.20 - 0.26 |
| 52 週範圍 | 0.07 - 0.91 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 OSRH
OSR Health, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Europe, and Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma completed phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antig...
完整的公司簡介財報驚奇
OSR Health 已於 Mar 31, 2026 公布季度財報：
- 營收為 $484.06K 低於預期 $0, 年增 -36.41% 下滑.
- 每股盈餘為 -0.16 低於預期 -0.06, 年增 -Infinity% 下滑.